The effects of parathyroid hormone‐related peptide on cardiac angiogenesis, apoptosis, and function in mice with myocardial infarction
- 17 April 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (9) , 14745-14755
Abstract
It is known that parathyroid hormone‐related peptide (PTHrP) contains a nuclear localization sequence (NLS, 87‐107), which, together with its C‐terminus (107‐139), has been shown to positively regulate vascular smooth muscle cell (VSMCs) proliferation and vascular neointima formation, and inhibit cellular apoptosis. The role of PTHrP in ischemic cardiac diseases remains unclear. In this study, we attempted to determine whether PTHrP 87 to 139 can play a role in promoting cardiac function via enhancing angiogenesis after myocardial infarction (MI) occurred. MI was reproduced in C57BL/6 mice using a coronary artery ligation method. In total, three groups (n = 11 per group) of animals were used, and they were received either PTHrP 87 to 139 (80 µg/kg, treatment group) or saline (MI and Sham group) subcutaneously once a day for 4 weeks after MI. To measure cardiac function, an echocardiography was generated and cardiac tissue was harvested for immunohistological studies 4 weeks after operation. Our results show that, after MI, the cardiac function of the experimental mice was significantly impaired. PTHrP 87 to 139 treatment attenuated cardiac dysfunction in MI mice. Besides, as indicated by decreased heart weight/body weight and lung weight/body weight ratio, PTHrP 87 to 139 attenuated pulmonary congestion and cardiac hypertrophy. Masson staining revealed that PTHrP 87 to 139 attenuated myocardial fibrosis after MI. Also, terminal deoxynucleotidyl transferase mediated dUTP nick‐end labeling staining and the expression of cleaved caspase 3 suggested that MI‐induced myocytes apotosis was inhibited by PTHrP 87 to 139. In addition to the significantly increased capillary density, PTHrP 87 to 139 treatment also induced p‐Akt and several angiogenic factors. In conclusion, PTHrP 87 to 139 treatment preserved cardiac function after MI, and stimulated angiogenesis via upregulating vascular endothelial growth factor and basic fibroblast growth factor (bFGF) in infarct border zone of ischemic myocardium,. These results suggest that PTHrP 87 to 139 is of therapeutic potential for MI.Keywords
Funding Information
- National Natural Science Foundation of China (81000058)
This publication has 30 references indexed in Scilit:
- Glutaredoxin-1 Overexpression Enhances Neovascularization and Diminishes Ventricular Remodeling in Chronic Myocardial InfarctionPLOS ONE, 2012
- Akt1–Mediated Skeletal Muscle Growth Attenuates Cardiac Dysfunction and Remodeling After Experimental Myocardial InfarctionCirculation: Heart Failure, 2012
- Signaling Required for Blood Vessel Maintenance: Molecular Basis and Pathological ManifestationsInternational Journal of Vascular Medicine, 2012
- The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivoJournal of Thrombosis and Haemostasis, 2010
- Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survivalRegulatory Peptides, 2009
- Erythropoietin Enhances the Angiogenic Potency of Autologous Bone Marrow Stromal Cells in a Rat Model of Myocardial InfarctionCardiology, 2006
- Parathyroid Hormone–Related Protein as a Regulator of pRb and the Cell Cycle in Arterial Smooth MuscleCirculation, 2004
- Coronary Atherosclerotic Smooth Muscle Cells Overexpress Human Parathyroid Hormone-Related PeptidesBiochemical and Biophysical Research Communications, 1994
- Immunochemical Characterization of Circulating Parathyroid Hormone–Related Protein in Patients with Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1990
- Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1988